HP Inc Appoints Former Pharmaceutical Executive as New CEO

HP Inc has appointed former GSK CEO Emma Walmsley to lead the organization, marking a transition from pharmaceutical leadership to the personal computing and printing sector. Walmsley, who previously served on the Microsoft board, assumes the role as the company faces significant headwinds in its core hardware segments.

Financial data for the first nine months of fiscal 2026 indicates a 10 percent revenue increase to $44.5 billion, though this growth is currently threatened by a contraction in the PC market. Global PC shipments declined by 20 percent in the third quarter, driven by DRAM supply shortages and rising component costs that have discouraged enterprise fleet upgrades.

Management faces pressure to navigate these supply chain constraints while addressing stagnant demand for AI-integrated hardware. The appointment introduces potential governance risks, as Walmsley lacks direct experience in tech operations and has previously faced scrutiny from activist investors regarding her strategic background. Future institutional stability will depend on the new leadership's ability to stabilize print revenue and manage investor expectations amid ongoing market volatility.